The Generics in Italy industry profile is an essential resource for top-level data and analysis covering the Generics industry. It includes data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading companies and demographic information. Scope * Contains an executive summary and data on value, volume and/or segmentation* Provides textual analysis of Generics in Italy's recent performance and future prospects* Incorporates in-depth five forces competitive environment analysis and scorecards * Includes a five-year forecast of Generics in Italy* The leading companies are profiled with supporting key financial metrics * Supported by the key macroeconomic and demographic data affecting the market Highlights * Detailed information is included on market size, measured by value and/or volume * Five forces scorecards provide an accessible yet in depth view of the market's competitive landscapeWhy you should buy this report * Spot future trends and developments * Inform your business decisions * Add weight to presentations and marketing materials * Save time carrying out entry-level researchMarket DefinitionFor the purposes of this Profile, a generic is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and all branded generics are included. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included. The market value is evaluated at ex-factory prices. Market volume is quantified here as the percentage of the total ethical pharmaceutical market volume in a country or region which is accounted for by generic drugs. It is therefore a generics penetration rate measure, not an absolute measure of market volume. All currency conversions were calculated at constant average annual 2009 exchange rates.For the purposes of this report, Europe consists of Western Europe and Eastern Europe.Western Europe comprises Belgium, Denmark, France, Germany, Italy, the Netherlands, Norway, Spain, Sweden, and the United Kingdom.Eastern Europe comprises the Czech Republic, Hungary, Poland, Romania, Russia, and Ukraine.

1. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Generics in Italy
Published on September 2010
Report Summary
The Generics in Italy industry profile is an essential resource for top-level data and analysis covering the Generics industry. It
includes data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape,
leading companies and demographic information.
Scope
* Contains an executive summary and data on value, volume and/or segmentation
* Provides textual analysis of Generics in Italy's recent performance and future prospects
* Incorporates in-depth five forces competitive environment analysis and scorecards
* Includes a five-year forecast of Generics in Italy
* The leading companies are profiled with supporting key financial metrics
* Supported by the key macroeconomic and demographic data affecting the market
Highlights
* Detailed information is included on market size, measured by value and/or volume
* Five forces scorecards provide an accessible yet in depth view of the market's competitive landscape
Why you should buy this report
* Spot future trends and developments
* Inform your business decisions
* Add weight to presentations and marketing materials
* Save time carrying out entry-level research
Market Definition
For the purposes of this Profile, a generic is defined as a copy of an ethical (prescription) drug formerly protected by patents that have
now expired. Both unbranded generics and all branded generics are included. However, off-patent drugs that continue to be offered
by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included. The
market value is evaluated at ex-factory prices. Market volume is quantified here as the percentage of the total ethical pharmaceutical
Generics in Italy Page 1/5

2. Find Industry reports, Company profiles
ReportLinker and Market Statistics
market volume in a country or region which is accounted for by generic drugs. It is therefore a generics penetration rate measure, not
an absolute measure of market volume. All currency conversions were calculated at constant average annual 2009 exchange rates.
For the purposes of this report, Europe consists of Western Europe and Eastern Europe.
Western Europe comprises Belgium, Denmark, France, Germany, Italy, the Netherlands, Norway, Spain, Sweden, and the United
Kingdom.
Eastern Europe comprises the Czech Republic, Hungary, Poland, Romania, Russia, and Ukraine.
Table of Content
TABLE OF CONTENTS
EXECUTIVE SUMMARY 2
MARKET OVERVIEW 7
Market definition 7
Research highlights 8
Market analysis 9
MARKET VALUE 10
MARKET VOLUME 11
MARKET SEGMENTATION II 12
FIVE FORCES ANALYSIS 13
Summary 13
Buyer power 15
Supplier power 16
New entrants 17
Substitutes 19
Rivalry 20
LEADING COMPANIES 21
Bayer AG 21
Mylan Laboratories Inc. 26
Novartis AG 29
Teva Pharmaceutical Industries 33
MARKET FORECASTS 37
Market value forecast 37
Market volume forecast 38
MACROECONOMIC INDICATORS 39
APPENDIX 41
Methodology 41
Industry associations 42
Related Datamonitor research 42
Disclaimer 43
ABOUT DATAMONITOR 44
Premium Reports 44
Summary Reports 44
Datamonitor consulting 44
Generics in Italy Page 2/5

3. Find Industry reports, Company profiles
ReportLinker and Market Statistics
LIST OF TABLES
Table 1: Italy generics market value: $ million, 2005'09 10
Table 2: Italy generics market volume: volume penetration, 2005'09 11
Table 3: Italy generics market segmentation II: % share, by value, 2009 12
Table 4: Bayer AG: key facts 21
Table 5: Bayer AG: key financials ($) 24
Table 6: Bayer AG: key financials (') 24
Table 7: Bayer AG: key financial ratios 24
Table 8: Mylan Laboratories Inc.: key facts 26
Table 9: Mylan Laboratories Inc.: key financials ($) 27
Table 10: Mylan Laboratories Inc.: key financial ratios 27
Table 11: Novartis AG: key facts 29
Table 12: Novartis AG: key financials ($) 30
Table 13: Novartis AG: key financial ratios 31
Table 14: Teva Pharmaceutical Industries: key facts 33
Table 15: Teva Pharmaceutical Industries: key financials ($) 35
Table 16: Teva Pharmaceutical Industries: key financial ratios 35
Table 17: Italy generics market value forecast: $ million, 2009'14 37
Table 18: Italy generics market volume forecast: volume penetration, 2009'14 38
Table 19: Italy size of population (million), 2005'09 39
Table 20: Italy gdp (constant 2000 prices, $ billion), 2005'09 39
Table 21: Italy gdp (current prices, $ billion), 2005'09 39
Table 22: Italy inflation, 2005'09 40
Table 23: Italy consumer price index (absolute), 2005'09 40
Table 24: Italy exchange rate, 2005'09 40
LIST OF FIGURES
Figure 1: Italy generics market value: $ million, 2005'09 10
Figure 2: Italy generics market volume: volume penetration, 2005'09 11
Figure 3: Italy generics market segmentation II: % share, by value, 2009 12
Figure 4: Forces driving competition in the generics market in Italy, 2009 13
Figure 5: Drivers of buyer power in the generics market in Italy, 2009 15
Figure 6: Drivers of supplier power in the generics market in Italy, 2009 16
Figure 7: Factors influencing the likelihood of new entrants in the generics market in Italy, 2009 17
Figure 8: Factors influencing the threat of substitutes in the generics market in Italy, 2009 19
Figure 9: Drivers of degree of rivalry in the generics market in Italy, 2009 20
Figure 10: Bayer AG: revenues & profitability 25
Figure 11: Bayer AG: assets & liabilities 25
Figure 12: Mylan Laboratories Inc.: revenues & profitability 28
Figure 13: Mylan Laboratories Inc.: assets & liabilities 28
Figure 14: Novartis AG: revenues & profitability 31
Figure 15: Novartis AG: assets & liabilities 32
Figure 16: Teva Pharmaceutical Industries: revenues & profitability 36
Figure 17: Teva Pharmaceutical Industries: assets & liabilities 36
Figure 18: Italy generics market value forecast: $ million, 2009'14 37
Figure 19: Italy generics market volume forecast: volume penetration, 2009'14 38
Generics in Italy Page 3/5

4. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
If you have any questions please visit http://www.reportlinker.com/notify/contact
Order Information
Please verify that the product information is correct and select the format(s) you require.
Generics in Italy
Product Formats
Please select the product formats and the quantity you require.
Digital Copy--USD 250.00 Quantity: _____
Contact Information
Please enter all the information below in BLOCK CAPITALS
Title: Mr Mrs Dr Miss Ms Prof
First Name: _____________________________ Last Name: __________________________________
Email Address: __________________________________________________________________________
Job Title: __________________________________________________________________________
Organization: __________________________________________________________________________
Address: __________________________________________________________________________
City: __________________________________________________________________________
Postal / Zip Code: __________________________________________________________________________
Country: __________________________________________________________________________
Phone Number: __________________________________________________________________________
Fax Number: __________________________________________________________________________
Generics in Italy Page 4/5

5. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Payment Information
Please indicate the payment method, you would like to use by selecting the appropriate box.
Payment by credit card Card Number: ______________________________________________
Expiry Date __________ / _________
CVV Number _____________________
Card Type (ex: Visa, Amex…) _________________________________
Payment by wire transfer Crédit Mutuel
RIB : 10278 07314 00020257701 89
BIC : CMCIFR2A
IBAN : FR76 1027 8073 1400 0202 5770 189
Payment by check UBIQUICK SAS
16 rue Grenette – 69002 LYON, FRANCE
Customer signature:
Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at
http://www.reportlinker.com/index/terms
Please fax this form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
Generics in Italy Page 5/5